Solid Biosciences Inc. (SLDB)
$6.87+0.73%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $676M
- Beta
- 2.44
- P/E (TTM)
- -3.62
- Short % float
- 16.27%
- Days to cover
- 7.7
- SI change
- -25.6%
- 1W
- +0.29%
- 1M
- -24.26%
- vs SPY 1W
- -0.87%
- vs SPY 1M
- -27.25%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SLDB?
- LOPJLB’s latest quantitative signal on Solid Biosciences Inc. (SLDB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SLDB in?
- Solid Biosciences Inc. (SLDB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Solid Biosciences Inc. (SLDB) do?
- Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, whi…